We are live on
!
Find out more
APC
Alpine Peaks Capital Portfolio holdings
AUM
$85.4M
1-Year Est. Return
11.24%
This Fund
S&P 500
This Quarter
Est. Return
-4.99%
1 Year Est. Return
+11.24%
3 Year Est. Return
+24.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$99.2M
AUM Growth
-$5.85M
(-5.6%)
Cap. Flow
+$1.67M
Cap. Flow
% of AUM
1.69%
Top 10 Holdings %
Top 10 Hldgs %
62.45%
Holding
21
New
–
Increased
12
Reduced
8
Closed
–
Avg Time Held Equity + Options
13.2
quarters
Top 10 Avg Time Held Equity + Options
6.7
quarters
Top 20 Avg Time Held Equity + Options
12.2
quarters
Avg Time Held Equity only
13.8
quarters
Top 10 Avg Time Held Equity only
6.7
quarters
Top 20 Avg Time Held Equity only
12.2
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Techne
TECH
|
+$1.35M |
| 2 |
Descartes Systems
DSGX
|
+$952K |
| 3 |
Medpace
MEDP
|
+$947K |
| 4 |
West Pharmaceutical
WST
|
+$846K |
| 5 |
HEICO Corp Class A
HEI.A
|
+$542K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Littelfuse
LFUS
|
+$1.07M |
| 2 |
Interparfums
IPAR
|
+$938K |
| 3 |
Rollins
ROL
|
+$774K |
| 4 |
Cognex
CGNX
|
+$752K |
| 5 |
Wabtec
WAB
|
+$725K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.06% |
| 2 | Industrials | 24.58% |
| 3 | Healthcare | 24.13% |
| 4 | Consumer Discretionary | 12.53% |
| 5 | Consumer Staples | 3.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Bright Horizons
BFAM
$3.35B
| $7.63M | 7.69% |
92,851
+3,200
| +4% | +$269K |
2021 Q4
17 quarters
|
|
|
2
West Pharmaceutical
WST
$25.9B
| $7.49M | 7.55% |
29,883
+3,400
| +13% | +$846K |
2021 Q4
17 quarters
|
|
3
US Physical Therapy
USPH
$1.27B
| $7.12M | 7.18% |
95,024
+3,800
| +4% | +$311K |
2021 Q4
17 quarters
|
|
|
4
HEICO Corp Class A
HEI.A
$31.1B
| $7.11M | 7.17% |
33,669
+2,200
| +7% | +$542K |
2021 Q4
17 quarters
|
|
|
5
Cognex
CGNX
$10.6B
| $5.97M | 6.02% |
121,919
-16,100
| -12% | -$752K |
2021 Q4
17 quarters
|
|
|
6
Littelfuse
LFUS
$10.9B
| $5.8M | 5.85% |
17,100
-3,300
| -16% | -$1.07M |
2024 Q2
7 quarters
|
|
|
7
Medpace
MEDP
$17.2B
| $5.45M | 5.5% |
11,356
+1,850
| +19% | +$947K |
2021 Q4
17 quarters
|
|
8
Evertec
EVTC
$1.77B
| $5.31M | 5.35% |
188,204
+8,500
| +5% | +$241K |
2021 Q4
17 quarters
|
|
9
Jack Henry & Associates
JKHY
$10.5B
| $5.1M | 5.14% |
32,247
+2,200
| +7% | +$377K |
2023 Q1
12 quarters
|
|
10
Trimble
TRMB
$14B
| $4.96M | 5% |
75,983
-5,100
| -6% | -$354K |
2021 Q4
17 quarters
|
|
|
11
Rollins
ROL
$15.4B
| $4.81M | 4.84% |
89,968
-13,000
| -13% | -$774K |
2022 Q1
16 quarters
|
|
|
12
Descartes Systems
DSGX
$7.09B
| $4.57M | 4.61% |
63,900
+12,900
| +25% | +$952K |
2025 Q1
4 quarters
|
|
13
Trex
TREX
$4.55B
| $4.46M | 4.49% |
122,339
-500
| -0.4% | -$20.1K |
2022 Q4
13 quarters
|
|
|
14
Wabtec
WAB
$48.4B
| $4.37M | 4.4% |
17,480
-3,000
| -15% | -$725K |
2021 Q4
17 quarters
|
|
15
Advanced Drainage Systems
WMS
$9.5B
| $4.21M | 4.24% |
30,670
-250
| -0.8% | -$38.7K |
2024 Q1
8 quarters
|
|
|
16
Bio-Techne
TECH
$11.4B
| $3.87M | 3.9% |
74,000
+22,500
| +44% | +$1.35M |
2025 Q1
4 quarters
|
|
|
17
Interparfums
IPAR
$3.58B
| $3.38M | 3.41% |
37,202
-9,893
| -21% | -$938K |
2021 Q4
17 quarters
|
|
18
Qualys
QLYS
$6.94B
| $3.07M | 3.09% |
34,905
+2,000
| +6% | +$222K |
2021 Q4
17 quarters
|
|
19
Barrett Business Services
BBSI
$766M
| $2.58M | 2.6% |
88,352
| – | – |
2021 Q4
17 quarters
|
|
20
TriNet
TNET
$2.99B
| $1.66M | 1.68% |
45,650
+6,000
| +15% | +$286K |
2024 Q2
7 quarters
|
|
21
CALL
Maravai LifeSciences
MRVI
$1.11B
| $283K | 0.29% |
100,000
+3,100
| +3% | +$10.5K |
2025 Q3
2 quarters
|
|
Similar funds
ELM
FWS
CL
AFR
YAG
N
BCM
PHIMC
Alpine Peaks Capital's Q1 2026 Portfolio in Review
As of Q1 2026, Alpine Peaks Capital held 21 positions worth $99.2M, down 5.6% from $105M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 0%. Alpine Peaks Capital opened no new positions and made no exits, leaving the 21-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Industrials and Healthcare.
- Alpine Peaks Capital added most to Bio-Techne in Q1 2026, an estimated $1.35M increase.
- Alpine Peaks Capital's biggest Q1 2026 reduction was Littelfuse, cutting an estimated $1.07M.
- Alpine Peaks Capital's ten largest holdings make up 62% of its $99.2M portfolio in Q1 2026.
- Alpine Peaks Capital opened 0 new positions and closed 0 in Q1 2026.
- Alpine Peaks Capital's portfolio value fell 5.6% quarter-over-quarter to $99.2M.
Based on Alpine Peaks Capital's 13F filing for Q1 2026, filed 15 May 2026.